EVENT BASKET: 0 ITEMS
login
  • Text size small
  • Text size large
TEXT SIZE
The British Society for Rheumatology
  • About us
  • Join BSR
  • Resources
  • Education and Events
  • Patient information
  • BHPR
  • Members
  • What is BSRBR?
  • Requesting data from BSRBR
  • Reporting adverse events
  • BSRBR News
    • BSRBR newsletters
    • BSRBR Events
    • BSR Ankylosing Spondylitis Register
  • BSRBR Governance
  • Certolizumab Pegol: Information
  • Tocilizumab: Information
  • Rituximab: Information
  • BSRBR Contacts
  • Home
  • BSR Biologics Register
  • BSRBR News
  • BSRBR newsletters
Printer Friendly

BSRBR newsletters

BSRBR News April 2011

BSRBR Abstracts April 2011

BSRBR e-News January 2011

BSRBR e-News October 2010

BSRBR News April 2010

BSRBR News October 2009

BSRBR News April 2009

BSRBR News October 2008

BSRBR News January 2008


  • Contact us
  • Sitemap
  • BSR, Bride House, 18-20 Bride Lane, London, EC4Y 8EE.
  • Telephone: +44 (0) 20 7842 0900
  • Facsimile: +44 (0) 20 7842 0901
  • Email: bsr@rheumatology.org.uk
  • VAT No.: 404 5637 66, Company Reg No.: 3470316, Charity No.: 1067124
  • Terms & conditions
  • Privacy
  • Credits
  • Website design agency services by dotAgency